[Effect of NUDT21 on Alternative Splicing of Transcripts in K562 Cells]. 2020

Lan Zhang, and Wei-Hua Zhang
Department of Hematology, The First Hospital of Shanxi Medical University,Taiyuan 030001, Shanxi Province, China.

OBJECTIVE To explore the effect of nudix hydrolase 21 (NUDT 21) on alternative splicing of transcripts in leukemia K562 cells. METHODS The K562 cell line was used as the research objects. The NUDT 21 was knocked-down by lentivirus vector, then the expression of transcripts before and after interference was determined by transcriptome sequencing (RNA seq). The bioinformatics methods including GO analysis and KEGG pathway analysis were used to analyze the changes of differentially expressed genes and 3' alternative splicing, then these changes were confirmed by qPCR. RESULTS After the NUDT 21 in K562 cells was knoced-down, the differentially expressed genes showed that 5 196 were up-regulated, 3 917 were down-regulated. GO analysis and KEGG pathway analysis showed that the very differentially expressed transcripts mainly related with cell adhesion and differentiation, hematopoietic cell lines and autoimmunity. There were 436 significant alternative splicing, which mainly involved in the regulation of some biological processes such as cell proliferation and metabolism. The ERBB2, MAPK kinase MKNK2, G protein-coupled receptor GRK6, eukaryotic translation elongation factor EEF1B2, cyclin L2 CCNL2, mitotic checkpoint protein BUB3 were changed by 3' alternative splicing. Among them the expression of variant 1 of ERBB2 mRNA decreased and variant 4 increased. CONCLUSIONS NUDT21 influences the cell biological function at a higher level by variously regulating ways, including 3' end APA.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D017398 Alternative Splicing A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different. RNA Splicing, Alternative,Splicing, Alternative,Alternate Splicing,Nested Transcripts,Alternate Splicings,Alternative RNA Splicing,Alternative RNA Splicings,Alternative Splicings,Nested Transcript,RNA Splicings, Alternative,Splicing, Alternate,Splicing, Alternative RNA,Splicings, Alternate,Splicings, Alternative,Splicings, Alternative RNA,Transcript, Nested,Transcripts, Nested
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D019295 Computational Biology A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets. Bioinformatics,Molecular Biology, Computational,Bio-Informatics,Biology, Computational,Computational Molecular Biology,Bio Informatics,Bio-Informatic,Bioinformatic,Biologies, Computational Molecular,Biology, Computational Molecular,Computational Molecular Biologies,Molecular Biologies, Computational
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562
D039223 Cleavage And Polyadenylation Specificity Factor An RNA-binding protein that recognizes the AAUAAA RNA SEQUENCE at the 3' end of MRNA. It contains four subunits of 30, 73, 100 and 160 kDa molecular size and combines with CLEAVAGE STIMULATION FACTOR to form a stable complex with mRNA that directs the 3' cleavage and polyadenylation reaction. CPSF 30K,CPSF Protein,CPSF-100-kDa Subunit,CPSF-160-kDa Subunit,CPSF-30-kDa Subunit,CPSF-73-kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 100-kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 160-kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 30-kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 73-kDa Subunit,Cleavage-Polyadenylation Specificity Factor,CPSF 100 kDa Subunit,CPSF 160 kDa Subunit,CPSF 30 kDa Subunit,CPSF 73 kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 100 kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 160 kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 30 kDa Subunit,Cleavage And Polyadenylation Specificity Factor, 73 kDa Subunit,Cleavage Polyadenylation Specificity Factor,Subunit, CPSF-100-kDa,Subunit, CPSF-160-kDa,Subunit, CPSF-30-kDa,Subunit, CPSF-73-kDa

Related Publications

Lan Zhang, and Wei-Hua Zhang
June 1987, Oncogene research,
Lan Zhang, and Wei-Hua Zhang
January 2018, Frontiers in immunology,
Lan Zhang, and Wei-Hua Zhang
June 1988, Genes & development,
Lan Zhang, and Wei-Hua Zhang
August 1997, Gene,
Lan Zhang, and Wei-Hua Zhang
August 2002, Infection and immunity,
Lan Zhang, and Wei-Hua Zhang
January 2001, Anticancer research,
Lan Zhang, and Wei-Hua Zhang
January 2008, Molecular genetics and genomics : MGG,
Lan Zhang, and Wei-Hua Zhang
October 1996, Gene,
Lan Zhang, and Wei-Hua Zhang
March 1993, European journal of clinical investigation,
Lan Zhang, and Wei-Hua Zhang
December 1986, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!